Immediate Impact
5 from Science/Nature 91 standout
Citing Papers
Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance
2022 Standout
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
2021 Standout
Works of David N. Rubin being referenced
Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery11Supported, in part, by grant NCC9-60 from the National Aeronautics and Space Administration, Houston, Texas, Grant #9951522V from the America Heart Association Ohio Local Chapter, Columbus, Ohio and Grant #R01 HL56688-01A1 from the National Institutes of Health, Bethesda, Maryland.22Presented, in part, at the 49th Annual Scientific Sessions of American College of Cardiology, March 2000, Anaheim, California.
2001
Effect of Sulbactam on Infections Caused by Imipenem-ResistantAcinetobacter calcoaceticusBiotypeanitratus
1993
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| David N. Rubin | 397 | 230 | 95 | 117 | 19 | 674 | |
| Anthony Dugard | 172 | 122 | 34 | 107 | 16 | 668 | |
| María Luisa Martínez | 187 | 41 | 21 | 244 | 25 | 745 | |
| Marty Allen | 422 | 126 | 24 | 231 | 8 | 663 | |
| Leslie S.T. Fang | 89 | 146 | 26 | 301 | 20 | 845 | |
| Nicola Galdieri | 129 | 19 | 55 | 172 | 25 | 680 | |
| Claude E. Forkner | 138 | 47 | 26 | 87 | 16 | 754 | |
| Jens Jensen | 455 | 200 | 40 | 47 | 32 | 820 | |
| J. Laurence Ransom | 74 | 156 | 43 | 109 | 35 | 641 | |
| Y. Castaing | 100 | 26 | 36 | 103 | 37 | 741 | |
| Filippo Boroli | 116 | 30 | 41 | 84 | 23 | 771 |
All Works
Loading papers...